IPO Stock Watch: Medical Device Maker Nevro Hits High
at Investor's Business Daily - Mon Dec 22, 4:45PM CST
JPMorgan raised its price target on Nevro (NVRO) to 42 from 34 and the stock rose 13% Monday, closing at an all-time high of 39.37. Nevro develops and markets an implantable spinal cord stimulation system called Senza, designed to treat chronic pain...
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), NVRO: 37.95 (-0.93)
St. Jude Medical to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Dec 22, 3:40PM CST
St. Jude Medical, Inc. (NYSE:STJ) will present at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14 in San Francisco. Daniel J. Starks, chairman, president and chief executive officer, will address the conference at 10:30 a.m. PST. The presentation will also be webcast live at investors.sjm.com.
JPM: 62.48 (unch), STJ: 66.67 (+0.67)
Philips Looks To Long-Time Laggard Volcano To Perk Up Its Healthcare Biz
Stephen Simpson, CFA - at Seeking Alpha - Fri Dec 19, 5:15AM CST
BSX: 13.13 (+0.07), PHG: 29.39 (-0.06), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67)
Global Electrophysiology Devices Market 2014-2018: Key Vendors are Boston Scientific, GE, Medtronic, Philips and St. Jude Medical
PR Newswire Europe - Thu Dec 18, 9:41AM CST
DUBLIN, Dec. 18, 2014 /PRNewswire/ --Research and Markets
MDT: 74.08 (+0.31), STJ: 66.67 (+0.67)
Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 13.13 (+0.07), SPNC: 34.50 (+0.59), ABT: 45.70 (-0.02), PHG: 29.39 (-0.06), MDT: 74.08 (+0.31), TRIV: 13.47 (-0.40), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02), ELGX: 15.35 (-0.06), ATRC: 18.76 (+0.13), NVDQ: 16.90 (+0.55)
CVS Health Up on Dividend Hike, Fresh Buyback, Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 12:49PM CST
CVS Health (CVS) will raise its quarterly cash dividend by 27% to 35 cents per share from the prior payout of 27.5 cents.
MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), CVS: 97.89 (+0.02), RAD: 7.26 (-0.09)
Global Markets For Vascular Closure Devices 2014
M2 - Wed Dec 17, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/2kgnwz/global_markets) has announced the addition of the "Global Markets For Vascular Closure Devices" report to their offering. This 2014 report provides a detailed assessment of the current and forecast market. The study also provides a detailed assessment of the competitive landscape including established companies and disruptive emerging companies. The analysis quantifies current and forecast patient populations, procedure volumes, and market size. Competitor sales, unit volumes, ASPs, and market shares are provided for each segment. Key Topics Covered: 1. Executive Summary 2. Overview 3. Vascular Closure Methods And Devices 4. Procedure Forecasts And Market Analysis 5. Company Profiles - Abbott Vascular - AccessClosure (Cardinal Health) - Advanced Vascular Dynamics - Benrikal Services - Cardiva Medical - Cordis Corporation (Johnson & Johnson) - Marine Polymer Technologies - Morris Innovative - Scion BioMedical - St. Jude Medical - TZ Medical - Terumo - Vascular Solutions For more information visit http://www.researchandmarkets.com/research/2k...al_markets
JNJ: 104.59 (+0.31), STJ: 66.67 (+0.67), VASC: 27.30 (+0.71)
St. Jude Medical's Quadra Allure Pacemaker Gets CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 11:30AM CST
The Quadra Allure MP CRT-P expands St. Jude Medical Inc.'s (STJ) heart failure portfolio which includes the CardioMEMS HF Monitoring System, implantable cardioverter defibrillators, quadripolar and multi-point pacing systems.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), STJ: 66.67 (+0.67), OSUR: 10.26 (+0.25)
St. Jude pacer cleared in Europe
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 7:21AM CST
STJ: 66.67 (+0.67)
Research and Markets: Global Electrophysiology Devices Market 2014-2018 With Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare & St. Jude Medical Dominating
Business Wire - Thu Dec 11, 4:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/55kx3t/global) has announced the addition of the "Global Electrophysiology Devices Market 2014-2018" report to their offering.
BSX: 13.13 (+0.07), STJ: 66.67 (+0.67)
Global Electrophysiology Devices Market 2014-2018 with Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare & St. Jude Medical Dominating
M2 - Thu Dec 11, 3:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/csq4cs/global) has announced the addition of the "Global Electrophysiology Devices Market 2014-2018" report to their offering. The Global Electrophysiology Devices market to grow at a CAGR of 7.68% over the period 2013-2018 An electrophysiology device studies the electrical properties of biological cells and tissues by measuring the voltage change of various biological cells, tissues, organs, and the body as a whole. This device is used for the diagnosis as well as treatment of effected system of the body due to abnormal electrical properties of cells and tissues. One key trend is the increase in strategic alliances and M&A among the vendors in this market. Vendors are increasingly forming strategic alliances and engaging in M&A to increase their market share. Strategic alliances help vendors gain new capabilities and access new technologies of other vendors in the market. According to the report, one of the major drivers in this market is the rise in the geriatric population, which according to the WHO, is expected to reach 2 billion by 2050. More emphasis is being placed on disease prevention by utilizing electrophysiological procedures for the diagnosis and treatment of various diseases in the areas of cardiology, neurology, ophthalmology, orthopedics, urology, and general physiology. Further, the report states that one of the major challenges in the market is the lack of skilled electrophysiologists that have expertise in the entire range of electrophysiological diagnostic and therapeutic procedures. Some of the electrophysiology devices used for diagnostic purposes include: - ECG devices - ECoG devices - ERG devices - EOG devices - EMG devices - EEG devices - Diagnostic electrophysiology catheters - X-ray systems Electrophysiology devices used for treatment include: - ICD - Cardiac pacemakers - CRT - Ablation catheters Key Vendors - Boston Scientific - GE Healthcare - Medtronic - Philips Healthcare - St. Jude Medical Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Global Electrophysiology Diagnostic Devices Market - Global Electrophysiology Treatment Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/csq4cs/global
BSX: 13.13 (+0.07), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67)
St. Jude Medical Announces CE Mark Approval of the World's Only MultiPoint Pacing Pacemaker
Business Wire - Thu Dec 11, 2:00AM CST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of the Quadra Allure MP(TM) cardiac resynchronization therapy pacemaker (CRT-P). The Quadra Allure MP is the world's first and only quadripolar CRT-P with the MultiPoint Pacing option, a technology that has been shown to enhance patients' response to CRT, potentially improving quality of life for patients with heart failure. The MultiPoint Pacing technology enables physicians to pace multiple locations on the left side of the heart, giving the clinician more choices to best optimize CRT pacing based on patient need and reducing the rate of CRT non-responders, as well as the likelihood of costly and invasive lead revision through a second intervention procedure.
STJ: 66.67 (+0.67)
St. Jude Medical to Present Data from 16 Research Abstracts and Highlight Its Product Portfolio at the 2014 North American Neuromodulation Society Meeting
Business Wire - Mon Dec 08, 7:01AM CST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, will present data from 16 clinical research programs at the upcoming North American Neuromodulation Society (NANS) meeting in Las Vegas, Nevada, December 11 - 14, 2014.
STJ: 66.67 (+0.67)
Health Care Equipment Stocks Technical Analysis - Boston Scientific, Becton Dickinson, St. Jude Medical, Accuray, and Symmetry Medical
PR Newswire - Fri Dec 05, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Becton Dickinson and Company (NYSE: BDX), St Jude Medical Inc. (NYSE: STJ), Accuray Inc. (NASDAQ: ARAY), and Symmetry Medical Inc. (NYSE: SMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 04, 2014, the NASDAQ Composite ended at 4,769.44, down 0.11%, the Dow Jones Industrial Average edged 0.07% lower, to finish the day at 17,900.10, and the S&P 500 closed at 2,071.92, down 0.12%. The losses were broad based as seven out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 811.12, down 0.12%, while the index has advanced 10.05% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.13 (+0.07), SMA: 9.27 (-0.04), BDX: 139.90 (+1.44), STJ: 66.67 (+0.67), ARAY: 7.54 (+0.19)
Will MedTech Gain from Republican Promises? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 12:00AM CST
Will MedTech Gain from Republican Promises? - Zacks Analyst Interviews
ABT: 45.70 (-0.02), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STE: 66.76 (+0.85), BAX: 74.45 (-0.04), COV: 103.35 (+0.57), SHPG: 209.29 (+0.07), STJ: 66.67 (+0.67), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16), SYK: 96.00 (-0.61)
Will MedTech Gain from Republican Promises? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 12:00AM CST
Will MedTech Gain from Republican Promises? - Industry Outlook
ABT: 45.70 (-0.02), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STE: 66.76 (+0.85), BAX: 74.45 (-0.04), COV: 103.35 (+0.57), SHPG: 209.29 (+0.07), STJ: 66.67 (+0.67), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16), SYK: 96.00 (-0.61)
Stryker (SYK) Rewards Shareholders with 13% Dividend Hike - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 11:30AM CST
Major orthopedic device manufacturer, Stryker Corp. (SYK), recently hiked its quarterly dividend by 13% to 34.5 cents per share from 30.5 cents.
JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), SYK: 96.00 (-0.61)
After Yesterday's Rally of 1.50% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Dec 03, 4:41PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $67.82 to a high of $69.42. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $68.38 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
STJ: 66.67 (+0.67)
Watch for St Jude Medical to Potentially Pullback After Gaining 1.50% Yesterday
Comtex SmarTrend(R) - Wed Dec 03, 4:41PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $67.82 to a high of $69.42. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $68.38 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
STJ: 66.67 (+0.67)